NorthStar and YAP Therapeutics to Develop and Manufacture Radiopharmaceutical Products
Within this collaboration, NorthStar will support the development of YAP Therapeutics' biologic products by supplying the radioisotope non-carrier added actinium-225 (n.c.a. Ac-225) and providing access to its radiopharmaceutical contract development and manufacturing (CDMO) services.
Radiopharmaceuticals | 09/01/2025 | By Aishwarya
Blue Earth Therapeutics Expands Partnership Deal with Seibersdorf Labor
Blue Earth Therapeutics Ltd. has expanded its manufacturing agreements with Seibersdorf Labor GmbH to include the manufacture of its investigational 225Ac-based radioligand therapy.
Radiopharmaceuticals | 16/08/2024 | By Aishwarya
Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals
Nusano Inc. has inked a supply agreement with PharmaLogic to provide a more efficient and reliable supply of critical radioisotopes.
Radiopharmaceuticals | 11/07/2024 | By Aishwarya
PharmaLogic Opens New Radiopharmaceutical Production Facility in Cincinnati
PharmaLogic Holdings Corp. has opened its new radiopharmaceutical production and research facility in Cincinnati, Ohio.
Radiopharmaceuticals | 23/04/2024 | By Aishwarya | 316
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy